SE356979B - - Google Patents

Info

Publication number
SE356979B
SE356979B SE15032/68A SE1503268A SE356979B SE 356979 B SE356979 B SE 356979B SE 15032/68 A SE15032/68 A SE 15032/68A SE 1503268 A SE1503268 A SE 1503268A SE 356979 B SE356979 B SE 356979B
Authority
SE
Sweden
Application number
SE15032/68A
Inventor
K Weber
K Zeile
P Danneberg
R Giesemann
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE356979B publication Critical patent/SE356979B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE15032/68A 1967-11-24 1968-11-06 SE356979B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1064767A AT280290B (de) 1967-11-24 1967-11-24 Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen

Publications (1)

Publication Number Publication Date
SE356979B true SE356979B (enExample) 1973-06-12

Family

ID=3623762

Family Applications (1)

Application Number Title Priority Date Filing Date
SE15032/68A SE356979B (enExample) 1967-11-24 1968-11-06

Country Status (13)

Country Link
AT (1) AT280290B (enExample)
BE (1) BE724364A (enExample)
BR (1) BR6804236D0 (enExample)
CH (1) CH523265A (enExample)
DE (1) DE1810423B2 (enExample)
DK (1) DK124950B (enExample)
ES (2) ES360410A1 (enExample)
FR (2) FR1593335A (enExample)
GB (1) GB1173540A (enExample)
IE (1) IE32504B1 (enExample)
IL (1) IL31146A (enExample)
NL (1) NL6815755A (enExample)
SE (1) SE356979B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914216A (en) * 1962-12-18 1975-10-21 Boehringer Sohn Ingelheim 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones
DE2117438A1 (de) * 1971-04-08 1972-10-19 CH. Boehringer Sohn, 6507 Ingelheim Neue substituiert 1,3-Dihydro-2H-1 ^-benzodiazepine^-one
BE793460A (fr) * 1971-12-29 1973-06-28 Boehringer Sohn Ingelheim Nouvelles 1-aryl-3h,1,4-benzodiazepine-2,5-(1h
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
PT1143946E (pt) * 1999-04-30 2004-05-31 Univ Michigan Utilizacao de benzodiazepinas para tratar doencas autoimunitarias induzidas por apoptose
US7144880B2 (en) 1999-04-30 2006-12-05 Regents Of The University Of Michigan Compositions relating to novel compounds and targets thereof
US7276348B2 (en) 1999-04-30 2007-10-02 Regents Of The University Of Michigan Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
US7691582B2 (en) 2002-09-27 2010-04-06 The Regents Of The University Of Michigan Methods of secretory vimentin detection and modulation
WO2006074358A1 (en) 2005-01-03 2006-07-13 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20070043033A1 (en) 2005-06-01 2007-02-22 The Regents Of The University Of Michigan Unsolvated benzodiazepine compositions and methods
EP2604269B1 (en) 2005-11-01 2014-09-24 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
CA2659549C (en) 2006-06-09 2013-07-30 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
CA2680017C (en) 2007-03-09 2013-11-12 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
KR20100017766A (ko) * 2007-05-10 2010-02-16 에이엠알 테크놀로지, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤조-1,4-디아제핀 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 이의 용도
WO2009036175A2 (en) 2007-09-14 2009-03-19 The Regents Of The University Of Michigan F1f0-atpase inhibitors and related methods
MX2010004857A (es) 2007-11-06 2010-07-28 Univ Michigan Compuestos de benzodiazepinona utiles en el tratamiento de afecciones de la piel.
WO2010030891A2 (en) 2008-09-11 2010-03-18 The Regents Of The University Of Michigan Aryl guanidine f1f0-atpase inhibitors and related methods
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
EP2470020A4 (en) 2009-09-18 2013-03-13 Univ Michigan BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH
CN102753544A (zh) 2009-11-17 2012-10-24 密执安大学评议会 具有治疗性能的1,4-苯并二氮杂*-2,5-二酮和相关化合物
WO2011062765A2 (en) 2009-11-17 2011-05-26 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
US11465978B2 (en) 2013-09-11 2022-10-11 The Administrators Of The Tulane Educational Fund Anthranilic amides and the use thereof

Also Published As

Publication number Publication date
IL31146A0 (en) 1969-01-29
FR1593335A (enExample) 1970-05-25
ES378977A1 (es) 1973-01-16
DE1810423B2 (de) 1973-03-22
CH523265A (de) 1972-05-31
BR6804236D0 (pt) 1973-02-08
NL6815755A (enExample) 1969-05-28
DE1810423C3 (enExample) 1973-10-11
AT280290B (de) 1970-04-10
BE724364A (enExample) 1969-05-22
GB1173540A (en) 1969-12-10
ES360410A1 (es) 1970-11-01
DE1810423A1 (de) 1969-10-09
IL31146A (en) 1972-04-27
IE32504B1 (en) 1973-08-22
FR8310M (enExample) 1970-11-23
IE32504L (en) 1969-05-24
DK124950B (da) 1972-12-11

Similar Documents

Publication Publication Date Title
AU425114B2 (enExample)
DE1810423C3 (enExample)
AU610966A (enExample)
BE692780A (enExample)
BE692553A (enExample)
BE711675A (enExample)
BE710951A (enExample)
AU97666A (enExample)
BE710000A (enExample)
BE709730A (enExample)
BE709526A (enExample)
BE703706A (enExample)
BE703561A (enExample)
BE693127A (enExample)
BE693075A (enExample)
BE693071A (enExample)
BE693070A (enExample)
BE692922A (enExample)
BE712009A (enExample)
BE692778A (enExample)
BE692654A (enExample)
BE692577A (enExample)
BE711897A (enExample)
BE692552A (enExample)
BE692492A (enExample)